Literature DB >> 9689056

Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6.

S Gaubatz1, J G Wood, D M Livingston.   

Abstract

E2F transcription factors play an important role in the regulation of cell cycle progression. We report here the cloning and characterization of an additional member of this family, E2F-6. E2F-6 lacks pocket protein binding and transactivation domains, and it is a potent transcriptional repressor that contains a modular repression domain at its carboxyl terminus. Overproduction of E2F-6 had no specific effect on cell cycle progression in asynchronously growing Saos2 and NIH 3T3 cells, but it inhibited entry into S phase of NIH 3T3 cells stimulated to exit G0. Taken together, these data suggest that E2F-6 can regulate a subset of E2F-dependent genes whose products are required for entry into the cell cycle but not for normal cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9689056      PMCID: PMC21314          DOI: 10.1073/pnas.95.16.9190

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Retinoblastoma protein switches the E2F site from positive to negative element.

Authors:  S J Weintraub; C A Prater; D C Dean
Journal:  Nature       Date:  1992-07-16       Impact factor: 49.962

2.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

3.  Identification of a growth suppression domain within the retinoblastoma gene product.

Authors:  X Q Qin; T Chittenden; D M Livingston; W G Kaelin
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

4.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

5.  An E2F-like repressor of transcription.

Authors:  M Morkel; J Wenkel; A J Bannister; T Kouzarides; C Hagemeier
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

6.  E2F-6, a member of the E2F family that can behave as a transcriptional repressor.

Authors:  J M Trimarchi; B Fairchild; R Verona; K Moberg; N Andon; J A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 7.  E2F: a nodal point in cell cycle regulation.

Authors:  R Bernards
Journal:  Biochim Biophys Acta       Date:  1997-12-09

8.  pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.

Authors:  R K Hurford; D Cobrinik; M H Lee; N Dyson
Journal:  Genes Dev       Date:  1997-06-01       Impact factor: 11.361

9.  The subcellular localization of E2F-4 is cell-cycle dependent.

Authors:  G J Lindeman; S Gaubatz; D M Livingston; D Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

10.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

View more
  59 in total

1.  p19ARF targets certain E2F species for degradation.

Authors:  F Martelli; T Hamilton; D P Silver; N E Sharpless; N Bardeesy; M Rokas; R A DePinho; D M Livingston; S R Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

3.  CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.

Authors:  E Vigo; H Müller; E Prosperini; G Hateboer; P Cartwright; M C Moroni; K Helin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

Authors:  M G Davenport; J S Pagano
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 5.  Therapeutic applications of transcription factor decoy oligonucleotides.

Authors:  M J Mann; V J Dzau
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

6.  Interaction of the Arabidopsis E2F and DP proteins confers their concomitant nuclear translocation and transactivation.

Authors:  Shunichi Kosugi; Yuko Ohashi
Journal:  Plant Physiol       Date:  2002-03       Impact factor: 8.340

7.  Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factor.

Authors:  Paloma H Giangrande; Timothy C Hallstrom; Chainarong Tunyaplin; Kathryn Calame; Joseph R Nevins
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

8.  E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.

Authors:  Luisa Di Stefano; Michael Rugaard Jensen; Kristian Helin
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

9.  Combinatorial gene control involving E2F and E Box family members.

Authors:  Paloma H Giangrande; Wencheng Zhu; Rachel E Rempel; Nina Laakso; Joseph R Nevins
Journal:  EMBO J       Date:  2004-03-04       Impact factor: 11.598

Review 10.  E2F1: a promising regulator in ovarian carcinoma.

Authors:  Lei Zhan; Yu Zhang; Wenyan Wang; Enxue Song; Yijun Fan; Bing Wei
Journal:  Tumour Biol       Date:  2016-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.